BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamamoto K, Okui R, Yamatodani A. Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H4 receptor antagonist against cisplatin-induced anorexia in mice. Naunyn Schmiedebergs Arch Pharmacol 2019;392:925-36. [PMID: 30919010 DOI: 10.1007/s00210-019-01646-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Dai Y, Nie K. Research Progress of Liujunzi Decoction in the Treatment of Tumor-Associated Anorexia. DDDT 2022;Volume 16:1731-1741. [DOI: 10.2147/dddt.s365292] [Reference Citation Analysis]
2 Dai Y, Chen S, Li Y, Zhang G, Bi P, Nie K. Liujunzi Decoction ameliorated cisplatin-induced anorexia by inhibiting the JAK-STAT signaling pathway and coordinating anorexigenic and orexigenic neuropeptides in rats. J Ethnopharmacol 2022;285:114840. [PMID: 34800646 DOI: 10.1016/j.jep.2021.114840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): The ultimate translational neuropeptides. J Intern Med 2022. [PMID: 35043499 DOI: 10.1111/joim.13406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
4 Church MK, Frischbutter S, Kolkhir P, Maurer M. The Pharmacology of Antihistamines. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00072-4] [Reference Citation Analysis]
5 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]